Clinical Trial Detail

NCT ID NCT03355794
Title A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Children's Hospital Medical Center, Cincinnati
Indications

fibrillary astrocytoma

malignant glioma

brain stem glioma

Therapies

Everolimus + Ribociclib

Age Groups: adult child

Additional content available in CKB BOOST